المؤلفون: Chen JY; Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, 40402, Taiwan.; Translation Research Core, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan., Lin PY; Proton Therapy and Science Center, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan R.O.C., Hong WZ; Proton Therapy and Science Center, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan R.O.C., Yang PC; Proton Therapy and Science Center, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan R.O.C., Chiang SF; Lab of Precision Medicine, Feng-Yuan Hospital, Ministry of Health and Welfare, Taichung, 42055, Taiwan., Chang HY; Proton Therapy and Science Center, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan R.O.C., Ke TW; Department of Colorectal Surgery, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan.; School of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan., Liang JA; Department of Radiation Oncology, China Medical University Hospital, China Medical University, Taichung, Taiwan.; Department of Radiation Oncology, School of Medicine, China Medical University, Taichung, 40402, Taiwan., Chen WT; Department of Colorectal Surgery, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan.; Department of Colorectal Surgery, China Medical University HsinChu Hospital, China Medical University, HsinChu, 302, Taiwan.; School of Medicine, China Medical University, Taichung, 40402, Taiwan., Chao KSC; Proton Therapy and Science Center, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan R.O.C.. 094032@tool.caaumed.org.tw.; Department of Radiation Oncology, China Medical University Hospital, China Medical University, Taichung, Taiwan. 094032@tool.caaumed.org.tw.; Department of Radiation Oncology, School of Medicine, China Medical University, Taichung, 40402, Taiwan. 094032@tool.caaumed.org.tw., Huang KC; Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, 40402, Taiwan. chihyang0425@mail.cmu.edu.tw.; Translation Research Core, China Medical University Hospital, China Medical University, Taichung, 40402, Taiwan. chihyang0425@mail.cmu.edu.tw.; Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung, 40402, Taiwan. chihyang0425@mail.cmu.edu.tw.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Apr 02; Vol. 73 (5), pp. 92. Date of Electronic Publication: 2024 Apr 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Topoisomerase I Inhibitors*/pharmacology , Topoisomerase I Inhibitors*/therapeutic use , Colorectal Neoplasms*/therapy, Camptothecin/*analogs & derivatives, Humans ; Cytosol ; Tumor Microenvironment

المؤلفون: Bali SK; Bogazici University, Department of Chemistry, Bebek, 34342, Istanbul, Turkey. balisem1@msu.edu.; Michigan State University, Department of Chemistry, East Lansing, Michigan 48824, USA., Haslak ZP; Bogazici University, Department of Chemistry, Bebek, 34342, Istanbul, Turkey. balisem1@msu.edu.; Université de Reims Champagne-Ardenne, Reims, 51687, France., Cifci G; Bogazici University, Department of Chemistry, Bebek, 34342, Istanbul, Turkey. balisem1@msu.edu., Aviyente V; Bogazici University, Department of Chemistry, Bebek, 34342, Istanbul, Turkey. balisem1@msu.edu.

المصدر: Organic & biomolecular chemistry [Org Biomol Chem] 2023 May 31; Vol. 21 (21), pp. 4518-4528. Date of Electronic Publication: 2023 May 31.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101154995 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-0539 (Electronic) Linking ISSN: 14770520 NLM ISO Abbreviation: Org Biomol Chem Subsets: MEDLINE

مواضيع طبية MeSH: Topoisomerase I Inhibitors*/pharmacology , Neoplasms*, Humans ; DNA/chemistry ; DNA Topoisomerases, Type I/chemistry ; Base Pairing ; Camptothecin/chemistry ; Enzyme Inhibitors/pharmacology

المؤلفون: Qi Y; Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, P. R. China., Liu G; Department of Pharmacy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, P. R. China.

المصدر: Drug delivery [Drug Deliv] 2021 Dec; Vol. 28 (1), pp. 171-182.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular* , Liver Neoplasms* , Microspheres*, Antineoplastic Agents, Phytogenic/*pharmacology , Berberine/*pharmacology , Camptothecin/*analogs & derivatives , Topoisomerase I Inhibitors/*pharmacology, Animals ; Antineoplastic Agents, Phytogenic/administration & dosage ; Antineoplastic Agents, Phytogenic/chemistry ; Berberine/administration & dosage ; Berberine/chemistry ; Camptothecin/administration & dosage ; Camptothecin/chemistry ; Camptothecin/pharmacology ; Cell Line, Tumor ; Drug Delivery Systems ; Drug Liberation ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/antagonists & inhibitors ; Mice ; Mice, Nude ; Rats ; Topoisomerase I Inhibitors/administration & dosage ; Topoisomerase I Inhibitors/chemistry ; Xenograft Model Antitumor Assays

المؤلفون: Iwasa S; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Morita S; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Park YS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Nakamura M; Department of Chemotherapy, Comprehensive Cancer Center, Aizawa Hospital, Matsumoto, Japan., Kotaka M; Department of Digestive Surgery, Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan., Nishina T; Department of Gastroenterology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Matsuoka H; Department of General Gastroenterological Surgery, Fujita Health University Hospital, Toyoake, Japan., Ahn JB; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea., Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea., Hong YS; Department of Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea., Han SW; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea., Cho SH; Department of Hematology-Oncology, Chonnam National University Hospital, Medical School, Gwangju, Korea., Zhang DS; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China., Fang WJ; Department of Medical Oncology, First Affiliated Hospital, Zhejiang University, Hangzhou, China., Bai L; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China., Yuan XL; Department of Gastrointestinal Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China., Yuan Y; Department of Medical Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Yamada Y; Comprehensive Cancer Center, National Center for Global Health and Medicine, Shizuoka, Japan.; Department of Medical Oncology, Hamamatsu University School of Medicine, Shizuoka, Japan., Sakamoto J; Tokai Central Hospital, Kakamigahara, Japan., Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, Korea.

المصدر: Cancer science [Cancer Sci] 2021 Nov; Vol. 112 (11), pp. 4669-4678. Date of Electronic Publication: 2021 Aug 31.

نوع المنشور: Equivalence Trial; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

مواضيع طبية MeSH: Genotype*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Camptothecin/*analogs & derivatives , Colorectal Neoplasms/*drug therapy , Deoxycytidine/*analogs & derivatives , Fluorouracil/*analogs & derivatives , Glucuronosyltransferase/*genetics , Topoisomerase I Inhibitors/*therapeutic use, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab/therapeutic use ; Camptothecin/adverse effects ; Camptothecin/therapeutic use ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Confidence Intervals ; Deoxycytidine/adverse effects ; Deoxycytidine/therapeutic use ; Female ; Fluorouracil/adverse effects ; Fluorouracil/therapeutic use ; Humans ; Leucovorin/adverse effects ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Prognosis ; Progression-Free Survival ; Topoisomerase I Inhibitors/adverse effects ; Treatment Outcome ; Young Adult

SCR Protocol: IFL protocol; capecitabine-irinotecan combination

المؤلفون: Zhang M; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China; School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China., Fu W; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China; Department of Pharmacy, Jingzhou Central Hospital, Jingzhou 434020, PR China., Zhu LZ; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China; School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China., Liu XF; Jinan AISI Pharmaceutical Technology Co., Ltd, Jinan 250104, PR China., Li L; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China. Electronic address: leileilesure@163.com., Peng LZ; Jinan AISI Pharmaceutical Technology Co., Ltd, Jinan 250104, PR China; Institute of Agro-Food Science and Technology Shandong Academy of Agricultural Sciences, Jinan 250100, PR China., Kai GY; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, PR China., Liu YQ; School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China. Electronic address: yqliu@lzu.edu.cn., Zhang ZJ; School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China., Xu CR; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China. Electronic address: xcr@hust.edu.cn.

المصدر: Life sciences [Life Sci] 2022 Dec 15; Vol. 311 (Pt A), pp. 121105. Date of Electronic Publication: 2022 Oct 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0631 (Electronic) Linking ISSN: 00243205 NLM ISO Abbreviation: Life Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Topotecan*/pharmacology , Topoisomerase I Inhibitors*/pharmacology , Pancreatic Neoplasms*/drug therapy, Animals ; Female ; Humans ; Mice ; Camptothecin ; Cell Line, Tumor ; DNA Topoisomerases, Type I/metabolism ; Molecular Docking Simulation ; Xenograft Model Antitumor Assays

المؤلفون: Madeddu F; Department of Computer Science, 'Sapienza' University of Rome, Piazzale Aldo Moro, 5, 00185 Rome, Italy., Di Martino J; Department of Ecological and Biological Sciences, Tuscia University, Largo dell'Università snc, 01100 Viterbo, Italy., Pieroni M; Department of Computer Science, 'Sapienza' University of Rome, Piazzale Aldo Moro, 5, 00185 Rome, Italy., Del Buono D; Department of Ecological and Biological Sciences, Tuscia University, Largo dell'Università snc, 01100 Viterbo, Italy., Bottoni P; Department of Computer Science, 'Sapienza' University of Rome, Piazzale Aldo Moro, 5, 00185 Rome, Italy., Botta L; Department of Ecological and Biological Sciences, Tuscia University, Largo dell'Università snc, 01100 Viterbo, Italy., Castrignanò T; Department of Ecological and Biological Sciences, Tuscia University, Largo dell'Università snc, 01100 Viterbo, Italy., Saladino R; Department of Ecological and Biological Sciences, Tuscia University, Largo dell'Università snc, 01100 Viterbo, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 24; Vol. 23 (23). Date of Electronic Publication: 2022 Nov 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: DNA Topoisomerases, Type I*/metabolism , Topoisomerase I Inhibitors*/pharmacology , Topoisomerase I Inhibitors*/chemistry, Humans ; Molecular Docking Simulation ; Enzyme Inhibitors/pharmacology ; Camptothecin ; DNA/chemistry ; Molecular Dynamics Simulation

المؤلفون: Deyme L; SMARTc, Centre de Recherche en Cancérologie de Marseille (CRCM), Faculté de Pharmacie, INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Marseille, France. laure.deyme@gmail.com., Barbolosi D; SMARTc, Centre de Recherche en Cancérologie de Marseille (CRCM), Faculté de Pharmacie, INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Marseille, France., Mbatchi LC; Laboratoire de Biochimie et Biologie Moléculaire, CHU Nîmes-Carémeau, Nîmes, France.; IRCM, Inserm U1194, Université de Montpellier, Montpellier, France., Tubiana-Mathieu N; Centre Hospitalier Universitaire de Limoges, Limoges, France., Ychou M; Institut Régional du Cancer de Montpellier (ICM)-Val d'Aurelle, Montpellier, France., Evrard A; Laboratoire de Biochimie et Biologie Moléculaire, CHU Nîmes-Carémeau, Nîmes, France.; IRCM, Inserm U1194, Université de Montpellier, Montpellier, France., Gattacceca F; SMARTc, Centre de Recherche en Cancérologie de Marseille (CRCM), Faculté de Pharmacie, INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Marseille, France.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Aug; Vol. 88 (2), pp. 247-258. Date of Electronic Publication: 2021 Apr 28.

نوع المنشور: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Camptothecin/*analogs & derivatives , Irinotecan/*pharmacokinetics , Topoisomerase I Inhibitors/*pharmacokinetics, Camptothecin/therapeutic use ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/metabolism ; Female ; Fluorouracil/therapeutic use ; Humans ; Irinotecan/therapeutic use ; Leucovorin/therapeutic use ; Male ; Oxaliplatin/therapeutic use ; Topoisomerase I Inhibitors/therapeutic use

SCR Protocol: IFL protocol

المؤلفون: Yang XY; Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, PR China., Zhao HY; Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, PR China., Lei H; Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, PR China., Yuan B; Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, PR China., Mao S; Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, PR China., Xin M; Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, PR China., Zhang SQ; Department of Medicinal Chemistry, School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, PR China.

المصدر: ChemMedChem [ChemMedChem] 2021 Mar 18; Vol. 16 (6), pp. 1000-1010. Date of Electronic Publication: 2020 Dec 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Camptothecin/*pharmacology , DNA Topoisomerases, Type I/*metabolism , Topoisomerase I Inhibitors/*pharmacology, Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Camptothecin/analogs & derivatives ; Camptothecin/chemistry ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Humans ; Mice ; Molecular Docking Simulation ; Molecular Structure ; Solubility ; Structure-Activity Relationship ; Topoisomerase I Inhibitors/chemical synthesis ; Topoisomerase I Inhibitors/chemistry ; Water/chemistry

المؤلفون: Gao F; Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.; Institute of Translation Medicine, Shanghai University, Shanghai 200444, China., Zhou J; Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University, 688 Yingbin Road, Jinhua 321004, China., Sun Y; Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China., Yang C; Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China., Zhang S; Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China., Wang R; Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China., Tan W; Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.; The Cancer Hospital of the University of Chinese Academy of Sciences, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.

المصدر: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2021 Mar 03; Vol. 13 (8), pp. 9457-9463. Date of Electronic Publication: 2020 Dec 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-8252 (Electronic) Linking ISSN: 19448244 NLM ISO Abbreviation: ACS Appl Mater Interfaces Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Aptamers, Nucleotide/*chemistry , Camptothecin/*analogs & derivatives , Camptothecin/*pharmacology , Drug Carriers/*chemistry , Topoisomerase I Inhibitors/*pharmacology, Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/metabolism ; Camptothecin/metabolism ; DNA/chemistry ; DNA Topoisomerases, Type I/metabolism ; Drug Design ; Drug Repositioning ; Drug Screening Assays, Antitumor ; HCT116 Cells ; Humans ; Molecular Docking Simulation ; Topoisomerase I Inhibitors/chemical synthesis ; Topoisomerase I Inhibitors/metabolism

المصدر: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2021 Feb 08; Vol. 63 (1617), pp. e25-e27. Date of Electronic Publication: 2021 Feb 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: The Medical Letter Country of Publication: United States NLM ID: 2985240R Publication Model: Electronic Cited Medium: Internet ISSN: 1523-2859 (Electronic) Linking ISSN: 0025732X NLM ISO Abbreviation: Med Lett Drugs Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*therapeutic use , Antineoplastic Agents, Immunological/*therapeutic use , Camptothecin/*analogs & derivatives , Immunoconjugates/*therapeutic use , Topoisomerase I Inhibitors/*therapeutic use , Triple Negative Breast Neoplasms/*drug therapy, Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Camptothecin/administration & dosage ; Camptothecin/adverse effects ; Camptothecin/therapeutic use ; Clinical Trials as Topic ; Drug Combinations ; Drug Interactions ; Female ; Glucuronosyltransferase/antagonists & inhibitors ; Glucuronosyltransferase/biosynthesis ; Humans ; Immunoconjugates/administration & dosage ; Immunoconjugates/adverse effects ; Survival Analysis ; Topoisomerase I Inhibitors/administration & dosage ; Topoisomerase I Inhibitors/adverse effects